Audentes Therapeutics (BOLD) Tops Q1 EPS by 20c
Tweet
Share
E-mail
Get Alerts BOLD Hot Sheet
Join SI Premium – FREE
Audentes Therapeutics (NASDAQ: BOLD) reported Q1 EPS of ($0.60), $0.20 better than the analyst estimate of ($0.80).
For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- General Mills (GIS) Tops Q1 EPS by 3c
- General Mills posts lower Q1 sales, reaffirms fiscal 2027 targets
- Seer and NTU to present early PRECISE-SG100K findings at HUPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
